StockNews.AI
PSEC
StockNews.AI
153 days

R-V Industries' to Participate in Several Upcoming Industry Events

1. R-V Industries showcases brand presence at major Pharma trade shows. 2. Recent acquisitions enhance R-V’s capabilities in pharmaceutical equipment. 3. Pharmaceutical sector contributes over 30% to R-V's annual revenue. 4. Prospect Capital Corporation supports R-V's growth through investments. 5. R-V aims to diversify and innovate in manufacturing markets.

6m saved
Insight
Article

FAQ

Why Bullish?

R-V's commitment to the pharmaceutical market can positively affect PSEC’s investment returns, as seen in previous successful strategic acquisitions.

How important is it?

R-V's strengthening position in the pharmaceutical industry directly supports Prospect Capital's valuation and performance projections, highlighting future growth potential.

Why Long Term?

Sustained growth in R-V’s pharmaceutical division is likely to enhance long-term profitability for PSEC, as seen with other portfolio companies that successfully expanded their markets.

Related Companies

RVIINTC
March 19, 2025 07:01 ET  | Source: R-V Industries HONEY BROOK, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- R-V will be participating in several upcoming industry events. Ackley, Beta Star, Genesis, and R.W. Hartnett will be exhibitors at the Interphex trade show April 1-3 in New York City. Ackley and R.W. Hartnett will be exhibiting at the CPHI show October 28-30 in Frankfurt, Germany. Having four of its brands at the world's biggest pharma-centric trade shows demonstrates R-V’s emergence as a significant player across the pharmaceutical landscape and is indicative of a company-wide commitment to manufacturing excellence, regardless of the industry. Market and product diversity has been a key differentiator of R-V Industries over its 51-year history. Fabricated steel products established R-V as an innovator in the Customer Fabrication, ASME Code Pressure Vessel, Nuclear, Paper, and Power markets since its founding in 1974.  “Our vision is to grow and diversify end markets and find specific niches where our innovative products, facilities, quality, and service create value for customers and growth opportunities for our employees,” said Kirk A. Putt, president and CEO of R-V. The Pharmaceutical market was one the company had been targeting. The opportunity to enter the Pharmaceutical, Life Science, and University Research markets materialized with the acquisition of Beta Star Life Science Equipment in 2007, a former customer of R-V’s. This acquisition expanded the identity of R-V, from a successful small business focused on industrial processing equipment to a global brand.  ​R-V and Beta Star were a natural fit, for many years R-V manufactured the ASME pressure chambers utilized on Beta Star autoclaves. R-V’s ASME Code division continues to manufacture chambers, reactors, tanks, and other stainless steel pressure vessels for pharmaceutical clients. By bringing Beta Star in-house, it allowed R-V to engineer new products while optimizing manufacturing processes. A series of acquisitions in the pharmaceutical industry followed, starting with Genesis Packaging Technologies (2017), now widely recognized as a worldwide leader in high-speed vial capping and residual seal force testing.  “Genesis is a great example of how we operate as a series of small companies outperforming larger competitors by providing the highest performing equipment in the industry and dynamic customer service,” said Putt. ​MBC Aerosol (Elgin, IL) was acquired in 2022. MBC provides aerosol/bag-on-valve filling and packaging lines for pharmaceutical and consumer goods. In June of 2023, R-V acquired Ackley Machine Corporation (Moorestown, NJ), a leader in pharmaceutical printing, laser marking, and laser drilling. This deal expanded R-V’s international customer base with the opportunity to work with leading global pharmaceutical brands. Less than a year later, R-V would acquire the longest tenured company in the pharmaceutical printing and laser marking market, R.W. Hartnett (Philadelphia), founded in 1880. R-V now features six divisions working in pharmaceutical and ancillary markets, generating over 30% of its $100mm annual revenue. These groups collaborate and share resources to innovate and service customer needs. About R-V Industries Founded in 1974, R-V Industries is a leading industrial equipment supplier. R-V’s industrial equipment solutions help produce many well-known consumer products and services, creating a better life for people around the world. With over 350 employees, R-V serves a diverse set of customers across biotechnology, chemical, consumer goods, food & beverage, life sciences, nuclear waste, oil & gas, paper & pulp, pharmaceutical, and power generation industries. R-V Industries is a portfolio company of Prospect Capital Corporation (NASDAQ: PSEC), a publicly traded business development company with $7.2 billion of total assets as of December 31, 2024. Prospect has provided capital to help complete R-V’s recent acquisitions. For further information, contact: Kirk A. Putt (KirkP@rvii.com)

Related News